You are Trying to View a Premium ArticleDaily News You Can't Find Anywhere Else
Lupin Launches Generic OCD Capsules in U.S., an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 87 Words
Attachment: India Pharm 0219
Indian pharmaceutical major Lupin Limited announced its launch of the antidepressant drug clomipramine hydrochloride in the U.S. market, following approval from the U.S. Food and Drug Administration
This Premium Article can be purchased individually or as part of a subscription
Subscribe Now! All Fields Required...
- Join Industrial Info for Our Global Industrial Predictive Analytics Using M...
- Biosimilar vs. Generic Pharmaceuticals, an Industrial Info Market Brief
- Thanks to Brexit, EMA Exits London for Amsterdam in March, an Industrial In...
- Alembic Pharma's Portfolio to Boom in 2019, an Industrial Info News Alert
- Investment in Medical Cannabis Increases in Portugal, an Industrial Info Ma...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker